Literature DB >> 24455767

Spontaneous activation of RNA-sensing pathways in autoimmune disease.

Steve P Crampton, Silvia Bolland.   

Abstract

Multiple intracellular RNA sensing innate immune pathways have been linked to autoimmune disease. RNA-related ligands taken up by the endocytic pathway activate TLRs, and affect primarily immune cells. This type of activation is enhanced by nucleic acid-specific antibodies and induces an inflammatory program. In contrast, spontaneous activation of cytoplasmic RNA sensing pathways targets mostly non-hematopoietic tissues and their effect on autoimmune disease is secondary to the release of interferon in the circulation. The fact that pathologies result from spontaneous activation of innate pathways implies that endogenous RNA ligands that might be sensed as pathogenic are commonly found in both immune and non-immune cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24455767      PMCID: PMC4100591          DOI: 10.1016/j.coi.2013.09.011

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  66 in total

1.  Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation.

Authors:  Maria L Mouchess; Nicholas Arpaia; Gianne Souza; Roman Barbalat; Sarah E Ewald; Laura Lau; Gregory M Barton
Journal:  Immunity       Date:  2011-11-10       Impact factor: 31.745

2.  Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.

Authors:  Irith Baumann; Wasilis Kolowos; Reinhard E Voll; Bernhard Manger; Udo Gaipl; Winfried L Neuhuber; Thomas Kirchner; Joachim R Kalden; Martin Herrmann
Journal:  Arthritis Rheum       Date:  2002-01

Review 3.  Interferon regulatory factors in human lupus pathogenesis.

Authors:  Rafah Salloum; Timothy B Niewold
Journal:  Transl Res       Date:  2011-02-08       Impact factor: 7.012

Review 4.  The mechanism of action of interferon-β in relapsing multiple sclerosis.

Authors:  Bernd C Kieseier
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

5.  Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking.

Authors:  Ryutaro Fukui; Shin-Ichiroh Saitoh; Atsuo Kanno; Masahiro Onji; Takuma Shibata; Akihiko Ito; Morikazu Onji; Mitsuru Matsumoto; Shizuo Akira; Nobuaki Yoshida; Kensuke Miyake
Journal:  Immunity       Date:  2011-06-16       Impact factor: 31.745

Review 6.  Intracellular nucleic acid sensors and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Dwight H Kono; Bruce Beutler; Roberto Baccala
Journal:  J Interferon Cytokine Res       Date:  2011-10-27       Impact factor: 2.607

7.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

8.  Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.

Authors:  Nicole A de Weerd; Julian P Vivian; Thao K Nguyen; Niamh E Mangan; Jodee A Gould; Susie-Jane Braniff; Leyla Zaker-Tabrizi; Ka Yee Fung; Samuel C Forster; Travis Beddoe; Hugh H Reid; Jamie Rossjohn; Paul J Hertzog
Journal:  Nat Immunol       Date:  2013-07-21       Impact factor: 25.606

9.  TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study.

Authors:  Aya Kawasaki; Hiroshi Furukawa; Yuya Kondo; Satoshi Ito; Taichi Hayashi; Makio Kusaoi; Isao Matsumoto; Shigeto Tohma; Yoshinari Takasaki; Hiroshi Hashimoto; Takayuki Sumida; Naoyuki Tsuchiya
Journal:  Arthritis Res Ther       Date:  2011-03-11       Impact factor: 5.156

10.  Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets.

Authors:  Tomoki Ito; Ryuichi Amakawa; Tsuneyasu Kaisho; Hiroaki Hemmi; Kenichirou Tajima; Kazutaka Uehira; Yoshio Ozaki; Hideyuki Tomizawa; Shizuo Akira; Shirou Fukuhara
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  6 in total

1.  A non-canonical cGAS-STING-PERK pathway facilitates the translational program critical for senescence and organ fibrosis.

Authors:  Dan Zhang; Yutong Liu; Yezhang Zhu; Qian Zhang; Hongxing Guan; Shengduo Liu; Shasha Chen; Chen Mei; Chen Chen; Zhiyong Liao; Ying Xi; Songying Ouyang; Xin-Hua Feng; Tingbo Liang; Li Shen; Pinglong Xu
Journal:  Nat Cell Biol       Date:  2022-05-02       Impact factor: 28.213

Review 2.  Advances in understanding the role of type I interferons in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 3.  Noncoding RNA Surveillance: The Ends Justify the Means.

Authors:  Cedric Belair; Soyeong Sim; Sandra L Wolin
Journal:  Chem Rev       Date:  2017-10-12       Impact factor: 60.622

Review 4.  Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus.

Authors:  Steve P Crampton; Peter A Morawski; Silvia Bolland
Journal:  Dis Model Mech       Date:  2014-09       Impact factor: 5.758

5.  Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade.

Authors:  Qian Zhang; Fansen Meng; Shasha Chen; Steven W Plouffe; Shiying Wu; Shengduo Liu; Xinran Li; Ruyuan Zhou; Junxian Wang; Bin Zhao; Jianming Liu; Jun Qin; Jian Zou; Xin-Hua Feng; Kun-Liang Guan; Pinglong Xu
Journal:  Nat Cell Biol       Date:  2017-03-27       Impact factor: 28.824

Review 6.  B-cell tolerance and autoimmunity.

Authors:  Takeshi Tsubata
Journal:  F1000Res       Date:  2017-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.